tiprankstipranks
Trending News
More News >
Essity (SE:ESSITY.A)
:ESSITY.A
Advertisement

Essity Aktiebolag (ESSITY.A) AI Stock Analysis

Compare
0 Followers

Top Page

SE:ESSITY.A

Essity Aktiebolag

(ESSITY.A)

Rating:74Outperform
Price Target:
kr286.00
▲(11.50% Upside)
Essity Aktiebolag's overall stock score reflects a balanced view of its financial stability, attractive valuation, and positive technical indicators. The company's strong balance sheet and reasonable P/E ratio are significant strengths. However, challenges in revenue growth and cash flow efficiency, along with mixed long-term technical signals, moderate the overall score.

Essity Aktiebolag (ESSITY.A) vs. iShares MSCI Sweden ETF (EWD)

Essity Aktiebolag Business Overview & Revenue Model

Company DescriptionEssity AB (publ) develops, produces, and sells hygiene and health products and services worldwide. It offers health and medical products, including incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology. It operates in Personal Care, Consumer Tissue, Professional Hygiene, and Other segments. The company also provides consumer goods, such as incontinence products, pads, diapers, wet wipes, skincare products, intimate soaps, washable absorbent underwear, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins; and professional hygiene products that consist of toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products. In addition, it offers digital solutions, such as Internet of Things sensor technology enabling data-driven cleaning, as well as related service and maintenance to companies and office buildings, universities, healthcare facilities, industries, restaurants, hotels, stadiums, and other public venues. The company markets its health and medical products under the TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Castbrands brands through pharmacies, medical devices stores, hospitals, distributors, and care institutions, as well as e-commerce; consumer goods products under the Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda brands through retail trade and online; and professional hygiene products under the TORK brand through distributors and online. It serves in Europe, North America, Latin America, Asia, and internationally. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.
How the Company Makes MoneyEssity generates revenue through the sale of its diverse range of hygiene and health products across multiple channels, including retail, e-commerce, and direct sales to businesses. The company's revenue model is primarily based on product sales, with key revenue streams coming from its Consumer segment (which includes personal care and tissue products) and Professional segment (which includes medical and hygiene products for healthcare facilities). Essity's strong brand portfolio, which includes well-known names like TENA, Libero, and Tempo, supports its market presence and pricing power. Additionally, strategic partnerships with retailers and distributors enhance its distribution capabilities, while a focus on sustainability and innovation attracts environmentally conscious consumers, further contributing to its earnings.

Essity Aktiebolag Earnings Call Summary

Earnings Call Date:Jul 17, 2025
(Q1-2025)
|
% Change Since: |
Next Earnings Date:Oct 23, 2025
Earnings Call Sentiment Neutral
Essity had a solid start to the year with strong cash flow, strategic buybacks, and product innovations. However, challenges such as higher COGS, volume declines in certain segments, and increased SG&A expenses posed pressures on margins.
Q1-2025 Updates
Positive Updates
Solid Start to 2025
Essity reported a solid performance with higher sales and strong cash flow. The company continued to see strong growth in high-margin categories, and overall stable volumes across its business areas.
New Share Buyback Program
Essity announced a new SEK3 billion share buyback program to allocate its strong operating cash flow, aiming to continue this as a recurring capital allocation strategy.
Product Innovation and Superiority
Essity launched new products, including a soft Consumer Tissue product in the U.K. and absorbent underwear. Product superiority reached over 70%, indicating a strong customer preference.
Limited Impact from Tariffs
Essity reported a very limited impact from tariffs, thanks to its global footprint and local production strategies.
Strong Cash Flow and Reduced Debt
Essity maintained a strong cash flow and further reduced its net debt to approximately SEK27 billion, with a net debt to EBITDA ratio of about 1.
Negative Updates
Higher COGS and Margin Pressure
The company faced higher costs of goods sold (COGS) due to increased raw material prices, particularly pulp, leading to pressure on margins.
Volume Decline in Professional Hygiene
Professional Hygiene saw a volume decline of 3.6%, particularly in North America, due to softer market demand.
Weakness in Baby Care Segment
The Baby Care segment experienced a 6.5% decline in sales, attributed to lower demand and strong competitive promotions.
SG&A Increase
Selling, General and Administrative expenses increased due to salary inflation and higher IT spending, impacting overall margins.
Company Guidance
During Essity's Q1 2025 earnings call, the company reported a solid start to the year with higher sales and strong cash flow across all business areas. Notably, Health & Medical and Professional Hygiene experienced robust growth in sales volume, mix, and pricing, despite some lower volumes in Professional Hygiene. The company faced increased cost of goods sold (COGS) due to higher raw material and distribution costs, as well as elevated SG&A expenses attributed to inflation and business expansion efforts. Essity announced a SEK3 billion share buyback program, leveraging its strong cash flow, and emphasized its commitment to organic growth, stable dividends, and deleveraging its solid balance sheet. The company launched new products, such as the Tena ProSkin slip, and reported that 71% of its branded sales are perceived as superior by customers, indicating a strong preference for Essity's offerings. Despite macroeconomic uncertainties and a limited impact from tariffs, Essity remains focused on accelerating profitable growth with an emphasis on volume, supported by its efficient supply chain and global market presence.

Essity Aktiebolag Financial Statement Overview

Summary
Essity Aktiebolag demonstrates a solid financial foundation with stable margins and effective debt management. However, the company faces challenges in revenue growth and cash flow efficiency. Strategic initiatives to enhance sales and optimize cash flow could bolster financial performance. The balance sheet remains strong, supporting future growth opportunities.
Income Statement
75
Positive
Essity Aktiebolag's income statement shows a mixed performance. The company has maintained a healthy gross profit margin of around 32-33% over the years, indicating efficient cost management. However, the net profit margin has seen a decline in the TTM period to 8.58% from 14.35% in 2024, reflecting potential challenges in maintaining profitability. Revenue growth has been negative in recent periods, with a TTM decline of 1.67%, suggesting a need for strategic initiatives to boost sales. Despite these challenges, the EBIT and EBITDA margins remain stable, showcasing operational efficiency.
Balance Sheet
70
Positive
The balance sheet reflects a stable financial position with a debt-to-equity ratio improving to 0.51 in the TTM period from 0.86 in 2023, indicating effective debt management. The return on equity (ROE) is strong at 14.82% in the TTM period, although it has decreased from 23.65% in 2024, suggesting a decline in profitability relative to shareholder equity. The equity ratio is not explicitly mentioned, but the overall leverage appears manageable, with a focus on maintaining equity levels.
Cash Flow
65
Positive
Cash flow analysis shows a decline in free cash flow growth by 10.86% in the TTM period, indicating potential cash management challenges. The operating cash flow to net income ratio is at 0.40, suggesting that the company generates sufficient cash from operations relative to its net income. However, the free cash flow to net income ratio has decreased to 0.53 from 0.56 in 2024, highlighting a need for improved cash flow efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue143.24B145.55B147.15B156.17B121.87B121.75B
Gross Profit46.78B47.13B45.13B37.23B35.09B39.44B
EBITDA25.69B26.14B20.90B15.44B20.45B24.89B
Net Income12.29B20.89B9.55B5.57B8.62B10.23B
Balance Sheet
Total Assets167.41B185.28B202.99B210.60B175.05B154.65B
Cash, Cash Equivalents and Short-Term Investments6.70B15.62B5.19B4.50B4.09B5.15B
Total Debt41.34B43.78B60.98B66.58B56.83B45.88B
Total Liabilities86.21B96.54B123.59B134.04B106.54B91.30B
Stockholders Equity80.80B88.31B70.85B67.35B59.87B54.35B
Cash Flow
Free Cash Flow7.91B9.40B14.68B5.92B7.31B11.21B
Operating Cash Flow15.04B16.80B21.57B12.87B14.67B17.82B
Investing Cash Flow-5.26B9.41B-7.11B-14.50B-12.13B-7.09B
Financing Cash Flow-16.10B-22.34B-11.55B1.81B-3.81B-8.38B

Essity Aktiebolag Technical Analysis

Technical Analysis Sentiment
Positive
Last Price256.50
Price Trends
50DMA
252.73
Positive
100DMA
263.34
Negative
200DMA
274.20
Negative
Market Momentum
MACD
1.37
Negative
RSI
58.69
Neutral
STOCH
43.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ESSITY.A, the sentiment is Positive. The current price of 256.5 is above the 20-day moving average (MA) of 252.40, above the 50-day MA of 252.73, and below the 200-day MA of 274.20, indicating a neutral trend. The MACD of 1.37 indicates Negative momentum. The RSI at 58.69 is Neutral, neither overbought nor oversold. The STOCH value of 43.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:ESSITY.A.

Essity Aktiebolag Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
kr177.49B14.50
3.22%-5.52%-35.37%
57
Neutral
$3.12B8.17-34.32%3.15%-25.56%-353.61%
$18.89B16.0114.51%2.70%
€389.63M19.616.56%
* Consumer Goods Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:ESSITY.A
Essity Aktiebolag
256.50
-53.41
-17.23%
ETTYF
Essity AB
27.34
-2.58
-8.62%
DE:2DU
Duni AB
8.14
0.02
0.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 05, 2025